{"SPADE_UN_00696": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2003/0096949 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2003_0096949_A1", "Patent Type": "Patent Application", "Publication Date": "2003-5-22", "Family Info": "CA2341340A1,CA2341340C,EP1107976A1,EP1107976A4,US6288212,US6818407,WO2000012528A1", "Patent Title": "Anti-endotoxic antimicrobial cationic peptides and methods of use therfor.", "Abstract": "A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."}, {"Patent No": "US 6818407 B2", "Patent Link": "http://www.lens.org/lens/patent/US_6818407_B2", "Patent Type": "Granted Patent", "Publication Date": "2004-11-16", "Family Info": "WO8900199,WO9638473", "Patent Title": "Antiendotoxic Antimicrobial Cationic Peptides And Methods Of Use Therfor", "Abstract": "A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO,3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO,22). Also provided are methods for inhibiting therowth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing."}], "Sequence Information": {"SPADE ID": "SPADE_UN_00696", "Peptide Name": "CPα3", "Source": "Synthetic construct", "Family": "Derived from the peptide CP26, CP29, CEME and CEMA", "Gene": "Not found", "Sequence": "KKWKKFIKKIGIGAVLTTPGAKK", "Sequence Length": 23, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram-"], "Target Organism": "Gram-negative bacteria:Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=32 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C122H210N32O26", "Mass": 2541.17, "PI": 10.85, "Net Charge": 8, "Hydrophobicity": -0.37, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against Gram-negative bacteria.", "Literature": [{"Title": "Biological properties of structurally related alpha-helical cationic antimicrobial peptides.", "Pubmed ID": "10085049", "Reference": "Infect Immun. 1999 Apr;67(4)2005-2009.", "Author": "Scott MG, Yan H, Hancock RE.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=10085049"}], "Frequent Amino Acids": "KGI", "Absent Amino Acids": "CDEHMNOQRSUY", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 10, "Polar Residues": 13, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13633", "Similarity": 1.0, "Sequence": "KKWWKKWK"}, {"SPADE_ID": "SPADE_UN_16208", "Similarity": 1.0, "Sequence": "KKWWKKWK"}, {"SPADE_ID": "SPADE_UN_22783", "Similarity": 1.0, "Sequence": "WKKIWKPGIKKWKK"}]}}}